EP2015803A4 - Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances - Google Patents

Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Info

Publication number
EP2015803A4
EP2015803A4 EP07835752A EP07835752A EP2015803A4 EP 2015803 A4 EP2015803 A4 EP 2015803A4 EP 07835752 A EP07835752 A EP 07835752A EP 07835752 A EP07835752 A EP 07835752A EP 2015803 A4 EP2015803 A4 EP 2015803A4
Authority
EP
European Patent Office
Prior art keywords
aspeeries
nanofibres
sequester
wear
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07835752A
Other languages
German (de)
English (en)
Other versions
EP2015803A2 (fr
Inventor
Darrell H Reneker
Daniel J Smith
David Barrett Meyers
Nevenka Golubovic-Liakopoulos
Alexander Marin
Alexander K Andrianov
Peter G Carroll
Sanford R Simon
Tao Han
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Akron
Apogee Technology Inc
Original Assignee
University of Akron
Apogee Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Akron, Apogee Technology Inc filed Critical University of Akron
Publication of EP2015803A2 publication Critical patent/EP2015803A2/fr
Publication of EP2015803A4 publication Critical patent/EP2015803A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
EP07835752A 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances Withdrawn EP2015803A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US79892806P 2006-05-09 2006-05-09
US84850606P 2006-09-29 2006-09-29
US84850706P 2006-09-29 2006-09-29
US84850506P 2006-09-29 2006-09-29
US84821306P 2006-09-29 2006-09-29
US84850406P 2006-09-29 2006-09-29
PCT/US2007/011228 WO2008024141A2 (fr) 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Publications (2)

Publication Number Publication Date
EP2015803A2 EP2015803A2 (fr) 2009-01-21
EP2015803A4 true EP2015803A4 (fr) 2009-05-06

Family

ID=39107260

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07835752A Withdrawn EP2015803A4 (fr) 2006-05-09 2007-05-09 Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances

Country Status (4)

Country Link
EP (1) EP2015803A4 (fr)
AU (1) AU2007288442A1 (fr)
CA (1) CA2650197A1 (fr)
WO (1) WO2008024141A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2817249T3 (es) 2007-04-16 2021-04-06 Corium Inc Matrices de microagujas obtenidas mediante disolución y colada que contienen un principio activo
WO2009048607A1 (fr) 2007-10-10 2009-04-16 Corium International, Inc. Distribution de vaccin par l'intermédiaire de réseaux de micro-aiguilles
BRPI0916150B1 (pt) * 2008-11-18 2019-09-24 3M Innovative Properties Company Arranjo de microagulhas ocas
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
CA2797204C (fr) * 2010-04-28 2018-06-12 Kimberly-Clark Worldwide, Inc. Dispositif pour administrer un medicament contre l'arthrite rhumatoide
AU2015271878B2 (en) * 2010-04-28 2017-05-11 Sorrento Therapeutics, Inc. Device for delivery of rheumatoid arthritis medication
RU2570280C2 (ru) 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
CN102985131B (zh) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 用于递送siRNA的医疗装置
EP2566501B1 (fr) * 2010-05-04 2019-03-13 Corium International, Inc. Méthode et dispositif permettant l'administration transdermique d'hormone parathyroïdienne au moyen d'un réseau de microprojections
WO2012130193A1 (fr) * 2011-03-31 2012-10-04 Zentiva, K.S. Complexes solubles non covalents de tériparatide contenant des polysaccharides et forme pharmaceutique de tériparatide pour administration orale
JP6535464B2 (ja) 2011-10-27 2019-06-26 ソレント・セラピューティクス・インコーポレイテッド 生理活性薬剤の送達のための移植可能な装置
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
BR112014009713A2 (pt) 2011-10-27 2017-04-18 Kimberly Clark Co administração transdérmica de agentes bioativos de alta viscosidade
WO2013086731A1 (fr) * 2011-12-16 2013-06-20 London Metropolitan University (Lmu) Appareil d'amenée
BR102012031954A2 (pt) * 2012-12-14 2015-01-20 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras com subtância ativa para aplicação cosmética de liberação controlada obtidas por eletrofiação e processo
BR102012031955A2 (pt) * 2012-12-14 2014-10-07 Instituto De Pesquisas Tecnológicas Do Est S. Paulo S/A Ipt Nanofibras contendo substância ativa com liberação controlada para aplicação odontológica e processo
EP2934660B1 (fr) 2012-12-21 2019-07-17 Corium, Inc. Micro-réseau pour la distribution d'un agent thérapeutique et son procédé de fabrication
EP4094799A1 (fr) 2013-03-12 2022-11-30 Corium, Inc. Applicateurs de microprojection
WO2014150285A2 (fr) 2013-03-15 2014-09-25 Corium International, Inc. Applicateurs de microprojection d'impacts multiples et procédés d'utilisation
US10384046B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
EP2968119B1 (fr) 2013-03-15 2019-09-18 Corium International, Inc. Micro-réseau pour administrer un agent thérapeutique, procédés d'utilisation et procédés de fabrication
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
KR101527469B1 (ko) * 2013-11-04 2015-06-11 연세대학교 산학협력단 다양한 삼차원 구조를 갖는 다공성 섬유 마이크로 구조체의 제조방법
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
JP7034425B2 (ja) * 2016-04-15 2022-03-14 エーディーエムバイオサイエンス インコーポレイテッド 核酸フィルムの製造方法及び核酸フィルムを用いた薬物注入装置
RU2019125715A (ru) 2017-01-23 2021-02-24 Афикс Терапьютикс А/С Способ изготовления двухслойного продукта на основе электроспряденных волокон
DE102017112573A1 (de) * 2017-06-07 2018-12-13 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation von Glukagon-ähnlichen-Peptid Analoga
CA3157209A1 (fr) * 2019-10-08 2021-04-15 Afyx Therapeutics A/S Compositions destinee a l'administration de proteines
US11642288B2 (en) * 2020-02-07 2023-05-09 Kao Corporation Skin external composition
CN121752175A (zh) * 2023-07-25 2026-03-27 小利兰·斯坦福大学托管委员会 涉及高密度生物电子纤维的装置和方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
WO2006027780A2 (fr) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137531A1 (en) * 1999-11-23 2005-06-23 Prausnitz Mark R. Devices and methods for enhanced microneedle penetration of biological barriers
US20050196380A1 (en) * 2004-03-08 2005-09-08 Mikszta John A. Method for delivering therapeutic proteins to the intradermal compartment
WO2006027780A2 (fr) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US20060085063A1 (en) * 2004-10-15 2006-04-20 Shastri V P Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering

Also Published As

Publication number Publication date
WO2008024141A3 (fr) 2008-04-24
WO2008024141A2 (fr) 2008-02-28
WO2008024141A8 (fr) 2009-07-09
EP2015803A2 (fr) 2009-01-21
CA2650197A1 (fr) 2008-02-28
AU2007288442A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
EP2015803A4 (fr) Structures de nanofibres présentes sur des aspérités destinées à séquestrer, porter et transférer des substances
EP1999317A4 (fr) Ensemble d'usure
BRPI0815277A2 (pt) "monitores de particulado"
EP1999654A4 (fr) Propagation de la pertinence de documents étiquetés à des documents non étiquetés
BRPI0714539A2 (pt) "formas farmacêuticas"
EP2021983A4 (fr) Ensemble de promotion
EP2366785A4 (fr) Dérivé d'oligonucléotide, agent de marquage et utilisation de l'agent de marquage
BRPI0809787A2 (pt) "respirador isento de manutenção"
DK2010159T3 (da) Paracetamoltabletter med hurtig frigivelse
BRPI0809898A2 (pt) "respirador isento de manutenção"
EP2340494A4 (fr) Partage sur un clic d'instantanés et de documents associés
BRPI0815430A2 (pt) "quantificação de amamentação"
DK2077729T3 (da) Orale probiotiske doseringsformer
BRPI0720333A2 (pt) "conexão de tubulação, conexão de tubulação roscada e mancal estampado"
EP2248091A4 (fr) Publicités ciblées sur des communautés
DE602007007073D1 (de) Rad- und bremsanordnungen
FR2898636B1 (fr) Structure de queue-d'aronde de soufflante.
DE602006018399D1 (de) Kegelrollenlager
EP2142216A4 (fr) Formulations de particule et utilisations de celles-ci
EP2139677A4 (fr) Améliorations concernant des nanocomposite et les surfaces de ceux-ci
EP1991691A4 (fr) Détection des facteurs de pathogénicité de l'anthrax
PL2839836T3 (pl) Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego
EP2323840A4 (fr) Améliorations dans des rouleaux d'ondulation
DE502008001462D1 (de) Schrägrollenlager
DE502007006015D1 (de) Wälzlager

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081025

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20090408

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090708